Daizo Koinuma

13PUBLICATIONS
21CO-AUTHORS
Molecular targetsTissue engineeringCancer therapy (excl. chemotherapy and radiation therapy)Neural engineeringPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 14, 2025
OCT-2 Is Associated With Pro-Metastatic Epigenomic Properties of Triple-Negative Breast Cancer Cells.

Kazuki Ogikubo, Jun Nishida, Kei Takahashi-Yamashiro

|Aug 08, 2024
Analysis of the DNA-binding properties of TGF-β-activated Smad complexes unveils a possible molecular basis for cellular context-dependent signaling.

Yuka Itoh, Kunio Miyake, Daizo Koinuma

|Dec 13, 2021
PolyI:C attenuates transforming growth factor-β signaling to induce cytostasis of surrounding cells by secreted factors in triple-negative breast cancer.

Yusuke Tamura, Shuichi Tsutsumi, Kohei Miyazono

|Jul 02, 2021
PRRX1 induced by BMP signaling decreases tumorigenesis by epigenetically regulating glioma-initiating cell properties via DNA methyltransferase 3A.

Ryo Tanabe, Kohei Miyazono, Tomoki Todo

|Dec 20, 2020
Anti-pyroptotic function of TGF-β is suppressed by a synthetic dsRNA analogue in triple negative breast cancer cells.

Yusuke Tamura, Masato Morikawa, Ryo Tanabe

|Jul 08, 2020
Targeting all transforming growth factor-β isoforms with an Fc chimeric receptor impairs tumor growth and angiogenesis of oral squamous cell cancer.

Kazuki Takahashi, Yuichi Akatsu, Katarzyna A Podyma-Inoue

Pageof 3

Frequent Collaborators

8 joint publications

Masato Morikawa

5 joint publications

Kohei Miyazono

2 joint publications

Tetsuro Watabe

1 joint publications

Taichi Kato